CD34 and neoplasm: The method used to evaluate microvessel density in tumours has been diversely evaluated, likely explaining the conflicting results in the literature (see review in Gasparini, 1996b, Charpin et al, 1997) when antipanendothelial CD34, CD31 or von Willebrand factor antibodies were applied in the immunocytochemical procedure.